Molecular_JJ Analysis_NN of_IN the_DT Pathogenicity_NP Locus_NP and_CC Polymorphism_NP in_IN the_DT Putative_JJ Negative_JJ Regulator_NN of_IN Toxin_NP Production_NP (_( TcdC_NP )_) among_IN Clostridium_NP difficile_NP Clinical_NP Isolates_VBZ The_DT pathogenicity_NN locus_NN (_( PaLoc_NP )_) of_IN Clostridium_NN difficile_NN contains_VBZ toxin_NN A_NP and_CC B_NP genes_NNS and_CC three_CD accessory_JJ genes_NNS ,_, including_VBG tcdD_NNS and_CC tcdC_NN ,_, which_WDT are_VBP supposed_VBN to_TO code_VB for_IN the_DT positive_JJ and_CC negative_JJ regulators_NNS of_IN toxin_NN expression_NN ,_, respectively_RB ._SENT Different_JJ studies_NNS have_VBP described_VBN variations_NNS in_IN C._NP difficile_NN toxin_NN A_NP and_CC B_NP genes_NNS ,_, but_CC little_RB is_VBZ known_VBN about_IN C._NP difficile_JJ variants_NNS for_IN the_DT accessory_JJ genes_NNS ._SENT The_DT PaLoc_NP of_IN several_JJ C._NP difficile_JJ clinical_JJ isolates_NNS was_VBD investigated_VBN by_IN three_CD different_JJ PCR_NP methods_NNS with_IN the_DT aim_NN to_TO identify_VB variant_JJ strains_NNS ._SENT Of_IN the_DT toxinogenic_JJ C._NP difficile_NN strains_NNS examined_VBD ,_, 25_CD %_NN showed_VBD variations_NNS ._SENT No_DT correlation_NN between_IN C._NP difficile_JJ variant_NN strains_NNS and_CC key_JJ patient_JJ groups_NNS was_VBD found_VBN ._SENT Interestingly_RB ,_, all_DT of_IN these_DT strains_NNS showed_VBD a_DT variant_JJ tcdC_NN gene_NN ._SENT Three_CD different_JJ tcdC_NN alleles_NNS were_VBD identified_VBN ,_, and_CC one_CD of_IN these_DT had_VBD a_DT nonsense_JJ mutation_NN which_WDT reduced_VBD the_DT TcdC_NP protein_NN from_IN 232_CD to_TO 61_CD amino_NN acids_NNS ._SENT It_PP is_VBZ possible_JJ that_IN different_JJ TcdC_NP variants_NNS affect_VBP toxin_NN production_NN differently_RB ,_, a_DT hypothesis_NN with_IN important_JJ implications_NNS for_IN the_DT pathogenic_JJ potential_NN of_IN variant_JJ C._NP difficile_NN strains_NNS ._SENT C._NP difficile_NP is_VBZ the_DT etiologic_JJ agent_NN of_IN pseudomembranous_JJ colitis_NN and_CC the_DT most_RBS common_JJ cause_NN of_IN nosocomial_JJ antibiotic-associated_JJ diarrhea_NN ._SENT Toxins_NNS A_NP and_CC B_NP ,_, C._NP difficile_JJ virulence_NN factors_NNS ,_, belong_VBP to_TO the_DT large_JJ clostridial_JJ cytotoxins_NNS ,_, and_CC both_CC disrupt_VB the_DT actin_NN cytoskeleton_NN ._SENT The_DT toxin_NN A_NP and_CC B_NP genes_NNS (_( tcdA_NN and_CC tcdB_NN )_) are_VBP part_NN of_IN the_DT pathogenicity_NN locus_NN (_( PaLoc_NP )_) ,_, a_DT 19.6-kb_JJ genetic_JJ locus_NN that_WDT also_RB includes_VBZ three_CD additional_JJ tcd_NNS open_JJ reading_NN frames_NNS (_( ORFs_NP )_) ,_, tcdD_NN ,_, tcdE_NNS ,_, and_CC tcdC_NN ,_, and_CC the_DT ORFs_NP for_IN the_DT insertion_NN sequences_NNS ,_, cdu-2_NN ,_, cdu-2_NN '_POS ,_, cdd-2_JJ cdd-3_NN ,_, and_CC cdd-4_NN ._SENT Sequencing_NP and_CC transcription_NN analysis_NN suggest_VBP that_IN TcdD_NP and_CC TcdC_NP are_VBP involved_VBN in_IN the_DT positive_JJ and_CC negative_JJ regulation_NN of_IN TcdA_NP and_CC TcdB_NP expression_NN ,_, respectively_RB ._SENT Different_JJ studies_NNS have_VBP described_VBN variations_NNS in_IN C._NP difficile_NN toxin_NN A_NP and_CC B_NP genes_NNS ._SENT Despite_IN the_DT fact_NN that_IN variant_JJ strains_NNS can_MD still_RB be_VB associated_VBN with_IN clinical_JJ diseases_NNS ,_, few_JJ epidemiological_JJ data_NNS on_IN their_PP$ circulation_NN are_VBP reported_VBN and_CC little_RB is_VBZ known_VBN about_IN PaLoc_NP accessory_JJ gene_NN variants_NNS ._SENT We_PP analyzed_VBD several_JJ C._NP difficile_JJ clinical_JJ isolates_NNS to_TO investigate_VB their_PP$ PaLocs_NP ,_, identify_VBP variant_JJ strains_NNS ,_, and_CC determine_VB possible_JJ correlations_NNS with_IN a_DT particular_JJ patient_NN population_NN ._SENT Three_CD different_JJ PCR-based_JJ methods_NNS were_VBD used_VBN to_TO detect_VB the_DT PaLoc_NP accessory_JJ genes_NNS ,_, the_DT variations_NNS in_IN the_DT toxin_NN A_NP and_CC B_NP genes_NNS ,_, and_CC the_DT presence_NN of_IN the_DT binary_JJ toxin_NN genes_NNS ._SENT The_DT majority_NN of_IN C._NP difficile_JJ strains_NNS with_IN dramatic_JJ variations_NNS in_IN toxin_NN A_NP and_CC B_NP genes_NNS harbor_VBP the_DT binary_JJ toxin_NN genes_NNS ,_, so_RB their_PP$ detection_NN is_VBZ suggested_VBN as_IN a_DT method_NN for_IN a_DT quick_JJ identification_NN of_IN these_DT strains_NNS ._SENT A_DT total_NN of_IN 51_CD C._NP difficile_NN strains_NNS ,_, isolated_VBN in_IN different_JJ Italian_JJ hospitals_NNS from_IN 1986_CD to_TO 1999_CD ,_, were_VBD examined_VBN ._SENT Six_CD strains_NNS were_VBD representative_JJ of_IN six_CD different_JJ outbreaks_NNS ,_, whereas_IN 24_CD strains_NNS were_VBD isolated_VBN from_IN sporadic_JJ cases_NNS and_CC 21_CD were_VBD isolated_VBN from_IN asymptomatic_JJ patients_NNS ._SENT C._NP difficile_NN VPI_NP 10463_CD and_CC C._NP difficile_NN ATCC_NP 43597_CD were_VBD used_VBN as_IN toxinogenic_JJ and_CC nontoxinogenic_JJ control_NN strains_NNS ,_, respectively_RB ._SENT C._NP difficile_NP strains_VBZ 51377_CD and_CC 57267_CD were_VBD used_VBN as_IN controls_NNS for_IN toxinotypes_NNS VI_NP and_CC VII_NP ,_, respectively_RB (_( a_DT description_NN of_IN the_DT toxinotyping_JJ method_NN can_MD be_VB viewed_VBN on-_NN line_VB at_IN )_) ._SENT The_DT in_IN vitro_NN production_NN of_IN toxins_NNS B_NP and_CC A_NP was_VBD assayed_VBN by_IN cytotoxicity_NN testing_NN and_CC an_DT enzyme_NN immunoassay_NN method_NN (_( Immunocard-Toxin_NP A_NP ;_: Meridian_NP Diagnostics_NP ,_, Cincinnati_NP ,_, Ohio_NP )_) ,_, respectively_RB ._SENT Five_CD microliters_NNS of_IN crude_NN extracts_VBZ of_IN DNA_NP was_VBD used_VBN for_IN multiplex_JJ PCRs_NNS and_CC binary_JJ toxin_NN gene_NN detection_NN ._SENT One_CD microliter_NN of_IN purified_VBN DNA_NN ,_, extracted_VBD using_VBG a_DT Nucleobond_NP AXG100_NP kit_NN (_( Macherey-Nagel_NP ,_, Duren_NP ,_, Germany_NP )_) ,_, was_VBD the_DT template_NN for_IN toxinotyping_NN and_CC amplification_NN of_IN the_DT entire_JJ tcdC_NN gene_NN ._SENT PaLoc_NP PCR_NP primers_NNS and_CC their_PP$ locations_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT Oligonucleotides_NNS were_VBD synthesized_VBN by_IN M-Medical_NP ,_, Florence_NP ,_, Italy_NP ._SENT FIG._NN 1_CD ._SENT |_SYM Primers_NP used_VBN in_IN the_DT PaLoc_NP analysis_NN ._SENT Primers_NNS used_VBN in_IN the_DT PaLoc_NP analysis_NN ._SENT (_( A_NP )_) Specificity_NN and_CC nucleotide_NN sequences_NNS of_IN primers_NNS and_CC molecular_JJ sizes_NNS of_IN the_DT PCR_NP products_NNS obtained_VBN for_IN each_DT pair_NN of_IN primers_NNS ._SENT (_( B_NP )_) Location_NP of_IN PCR_NP primers_NNS on_IN a_DT schematic_JJ representation_NN of_IN the_DT PaLoc_NP region_NN ._SENT The_DT small_JJ arrowheads_NNS indicate_VBP the_DT orientation_NN of_IN primers_NNS ._SENT Toxin_NN A_NP and_CC B_NP genes_NNS ,_, tcdA_NN and_CC tcdB_NN ,_, were_VBD amplified_VBN by_IN a_DT multiplex_JJ PCR_NP assay_NN ._SENT The_DT reaction_NN mixture_NN contained_VBN 1x_NP buffer_NN (_( 10_CD mM_NP Tris-HCl_NP ,_, 50_CD mM_NP KCl_NP ,_, 1.5_CD mM_NP MgCl2_NP )_) ,_, 200_CD pmol_NN of_IN each_DT deoxynucleoside_NN triphosphate_NN ,_, 100_CD pmol_NN of_IN TA1_NP and_CC TA2_NP primers_NNS ,_, 25_CD pmol_NN of_IN TB1_NP and_CC TB2_NP primers_NNS ,_, and_CC 2.5_CD U_NN of_IN Takara_NP rTaq_NP (_( Takara_NP Shuzo_NP Co._NP ,_, Ltd._NP ,_, Shiga_NP ,_, Japan_NP )_) ._SENT The_DT template_NN was_VBD denatured_VBN for_IN 5_CD min_NN at_IN 94C_NN ,_, and_CC DNA_NP was_VBD amplified_VBN for_IN 30_CD cycles_NNS consisting_VBG of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 50C_NN ,_, and_CC 1_CD min_NN at_IN 72C_NP ._SENT Multiplex_JJ PCR_NP for_IN the_DT PaLoc_NP accessory_JJ genes_NNS detection_NN was_VBD performed_VBN as_IN described_VBN by_IN Cohen_NP et_FW al._FW ._SENT The_DT same_JJ cycling_NN conditions_NNS were_VBD employed_VBN to_TO amplify_VB the_DT entire_JJ tcdC_NN gene_NN by_IN using_VBG primers_NNS C1_NP and_CC C2_NP ._SENT The_DT reaction_NN mixture_NN was_VBD prepared_VBN as_IN described_VBN for_IN toxin_NN A_NP and_CC B_NP detection_NN ._SENT Sequencing_NP was_VBD performed_VBN with_IN a_DT Perkin-Elmer_NP ABI373A_NP DNA_NP sequencer_NN ._SENT The_DT deduced_VBN amino_NN acid_NN sequence_NN was_VBD obtained_VBN by_IN the_DT ORF_NP Finder_NP program_NN ,_, whereas_IN the_DT nucleotide_NN and_CC amino_NN acid_NN sequences_NNS were_VBD compared_VBN with_IN database_NN entries_NNS by_IN using_VBG the_DT BLAST_NP program_NN ._SENT Toxinotyping_NP is_VBZ a_DT PCR-restriction_NN fragment_NN length_NN polymorphism_NN (_( RFLP_NP )_) method_NN consisting_VBG of_IN the_DT amplification_NN of_IN two_CD toxin_NN fragments_NNS ,_, B1_JJ from_IN tcdB_NN and_CC A3_NN from_IN tcdA_NN ,_, and_CC of_IN their_PP$ digestion_NN by_IN specific_JJ restriction_NN enzymes_NNS to_TO obtain_VB patterns_NNS characterizing_VBG the_DT different_JJ variants_NNS of_IN the_DT toxin_NN genes_NNS ._SENT We_PP followed_VBD the_DT method_NN reported_VBD in_IN the_DT toxinotyping_JJ home_NN page_NN ,_, with_IN some_DT minor_JJ modifications_NNS ._SENT The_DT PCR_NP mixture_NN contained_VBD 10_CD mM_NP Tris-HCl_NP ,_, 50_CD mM_NP KCl_NP ,_, 1.5_CD mM_NP MgCl2_NP ,_, 400_CD pmol_NN of_IN each_DT deoxynucleoside_NN triphosphate_NN ,_, 100_CD pmol_NN of_IN primers_NNS ,_, and_CC 2.5_CD U_NN of_IN Takara_NP ExTaq_NP (_( Takara_NP Shuzo_NP Co._NP ,_, Ltd._NP )_) ._SENT After_IN a_DT denaturation_NN of_IN 5_CD min_NN at_IN 94C_NN ,_, the_DT DNA_NN was_VBD amplified_VBN by_IN 30_CD cycles_NNS of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 47C_JJ ,_, and_CC 5_CD min_NN at_IN 72C_NP ._SENT At_IN the_DT end_NN ,_, samples_NNS were_VBD held_VBN at_IN 72C_NP for_IN 10_CD min_NN ._SENT PCR_NP fragments_NNS were_VBD purified_VBN with_IN a_DT QIAquick_NP PCR_NP purification_NN kit_NN (_( Qiagen_NP )_) and_CC digested_VBN ._SENT Internal_JJ regions_NNS of_IN binary_JJ toxin_NN genes_NNS were_VBD detected_VBN as_IN previously_RB described_VBN ._SENT Two_CD specific_JJ primers_NNS ,_, BIN5_NP (_( 5_CD '_POS AAT_NP ATT_NP GGG_NP AGG_NP GAG_NP AAT_NP AAA_NP TG_NP 3_CD '_'' )_) and_CC BIN6_NP 5_CD '_'' (_( TGT_NP ATT_NP TTC_NP ATT_NP GTT_NP TCT_NP CCT_NP CC_NP 3_CD '_'' )_) ,_, were_VBD designed_VBN to_TO amplify_VB the_DT entire_JJ ctdA_NN gene_NN ,_, which_WDT codes_VBZ for_IN the_DT enzymatic_JJ toxin_NN component_NN ,_, and_CC two_CD other_JJ primers_NNS ,_, BIN7_JJ (_( 5_CD '_POS ATT_NP GTT_NP GAT_NP GCA_NP ACA_NP TTG_NP ATA_NP CC_NP 3_CD '_'' )_) and_CC BIN8_NP (_( 5_CD '_POS AAT_NP ATA_NP TAT_NP TGT_NP ATT_NP GAG_NP GGG_NP AC_NP 3_CD '_'' )_) ,_, were_VBD designed_VBN to_TO amplify_VB the_DT entire_JJ cdtB_NN gene_NN ,_, which_WDT codes_VBZ for_IN the_DT binding_JJ toxin_NN component_NN ._SENT The_DT reaction_NN mixture_NN and_CC the_DT cycling_NN conditions_NNS were_VBD the_DT same_JJ as_RB described_VBN for_IN toxin_NN A_NP and_CC B_NP detection_NN ._SENT Different_JJ studies_NNS have_VBP demonstrated_VBN a_DT great_JJ heterogeneity_NN in_IN C._NP difficile_NN toxin_NN A_NP and_CC B_NP genes_NNS ._SENT This_DT characteristic_NN has_VBZ been_VBN successfully_RB used_VBN for_IN C._NP difficile_JJ strain_NN typing_VBG ,_, in_IN addition_NN to_TO the_DT other_JJ methods_NNS already_RB known_VBN ._SENT On_IN the_DT other_JJ hand_NN ,_, there_EX are_VBP few_JJ data_NNS on_IN C._NP difficile_JJ strains_NNS with_IN variant_JJ PaLoc_NP accessory_JJ genes_NNS and_CC on_IN their_PP$ circulation_NN among_IN patients_NNS ._SENT We_PP examined_VBD the_DT PaLoc_NN of_IN several_JJ C._NP difficile_NN strains_NNS isolated_VBN from_IN clinical_JJ samples_NNS to_TO acquire_VB further_JJR information_NN ._SENT A_DT total_NN of_IN 51_CD C._NP difficile_NN strains_NNS were_VBD examined_VBN ,_, and_CC 32_CD tested_VBN as_IN toxinogenic_JJ ._SENT The_DT analysis_NN of_IN the_DT PaLoc_NP accessory_JJ genes_NNS demonstrated_VBD that_DT 8_CD (_( 25_CD %_NN )_) of_IN the_DT 32_CD toxigenic_JJ strains_NNS showed_VBD a_DT different_JJ pattern_NN than_IN that_DT of_IN the_DT control_NN strain_NN ,_, VPI_NP 10463_CD (_( Table_NP ;_: Fig._NN )_) ._SENT Six_CD strains_NNS ,_, Pd5_NP ,_, Pd7_NP ,_, Pd13_NP ,_, Pd16_NP ,_, Pd53_NP ,_, and_CC Pd55_NP ,_, showed_VBD a_DT pattern_NN with_IN only_RB four_CD bands_NNS ,_, 622_CD ,_, 300_CD ,_, 262_CD ,_, and_CC 162_CD bp_NN in_IN size_NN ,_, apparently_RB corresponding_JJ to_TO the_DT genes_NNS cdd3_NN ,_, tcdD_NNS ,_, tcdE_NNS ,_, and_CC cdu2_NN ,_, respectively_RB ._SENT Two_CD single_JJ PCRs_NNS ,_, for_IN tcdC_NN and_CC tcdD_JJ internal_JJ fragments_NNS ,_, were_VBD performed_VBN separately_RB on_IN these_DT strains_NNS ._SENT Unexpectedly_RB ,_, we_PP obtained_VBD a_DT product_NN of_IN approximately_RB 300_CD bp_NN in_IN both_DT PCR_NP assays_VBZ from_IN all_PDT the_DT strains_NNS analyzed_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT A_DT deletion_NN in_IN the_DT tcdC_NN fragment_NN explained_VBD its_PP$ comigration_NN with_IN the_DT tcdD_NN fragment_NN ._SENT The_DT same_JJ deletion_NN was_VBD also_RB observed_VBN in_IN the_DT tcdC_NN gene_NN of_IN control_NN C._NP difficile_NP strains_VBZ 51377_CD and_CC 57267_CD ._SENT Two_CD strains_NNS ,_, M7_JJ and_CC Pd3_NP ,_, showed_VBD a_DT tcdC_NN fragment_NN smaller_JJR than_IN expected_VBN ._SENT Six_CD C._NP difficile_NN strains_NNS were_VBD also_RB recognized_VBN as_IN variant_JJ strains_NNS for_IN the_DT toxin_NN A_NP and_CC B_NP genes_NNS ._SENT Four_CD strains_NNS could_MD be_VB classified_VBN as_IN toxinotype_NN V_CD ,_, and_CC two_CD strains_NNS could_MD be_VB classified_VBN as_IN toxinotype_NN VI_NP ._SENT It_PP has_VBZ already_RB been_VBN suggested_VBN that_IN toxinotypes_NNS VI_CD and_CC V_CD are_VBP closely_RB related_VBN ._SENT In_IN this_DT study_NN ,_, all_PDT the_DT strains_NNS belonging_VBG to_TO these_DT two_CD toxinotypes_NNS were_VBD isolated_VBN from_IN cases_NNS which_WDT occurred_VBD in_IN different_JJ departments_NNS of_IN the_DT same_JJ hospital_NN from_IN 1997_CD to_TO 1999_CD ,_, suggesting_VBG persistent_JJ circulation_NN of_IN these_DT variant_JJ strains_NNS ._SENT Few_JJ data_NNS are_VBP reported_VBN on_IN the_DT role_NN of_IN variant_JJ C._NP difficile_NN strains_NNS in_IN causing_VBG severe_JJ disease_NN ;_: therefore_RB ,_, it_PP is_VBZ interesting_JJ that_IN these_DT C._NP difficile_NN variant_NN strains_NNS were_VBD responsible_JJ both_CC for_IN sporadic_JJ cases_NNS of_IN antibiotic-associated_JJ diarrhea_NN and_CC for_IN an_DT outbreak_NN ._SENT The_DT infections_NNS caused_VBN by_IN this_DT particular_JJ group_NN of_IN C._NP difficile_JJ variant_NN strains_NNS were_VBD not_RB age_NN related_VBN ,_, and_CC there_EX was_VBD no_DT correlation_NN with_IN a_DT particular_JJ patient_NN population_NN ._SENT Both_DT genes_NNS encoding_VBG the_DT binary_JJ toxin_NN were_VBD detected_VBN in_IN seven_CD of_IN the_DT eight_CD variant_JJ strains_NNS (_( data_NNS not_RB shown_VBN )_) ,_, including_VBG C._NP difficile_NP M7_NP ,_, which_WDT was_VBD recognized_VBN as_IN toxinotype_NN 0_CD ._SENT On_IN the_DT contrary_NN ,_, Pd3_NP ,_, the_DT other_JJ strain_NN belonging_VBG to_TO toxinotype_NN 0_CD and_CC showing_VBG a_DT variant_JJ tcdC_NN gene_NN ,_, did_VBD not_RB have_VB the_DT binary_JJ toxin_NN genes_NNS ._SENT Specific_JJ PCRs_NN for_IN cdtA_NN and_CC cdtB_NN confirmed_VBD the_DT absence_NN of_IN the_DT binary_JJ toxin_NN genes_NNS in_IN all_PDT the_DT other_JJ toxigenic_JJ C._NP difficile_NN strains_NNS ._SENT The_DT entire_JJ PaLocs_NP of_IN C._NP difficile_NP M7_NP and_CC Pd3_NP were_VBD analyzed_VBN by_IN PCR-RFLPs_NP to_TO verify_VB the_DT absence_NN of_IN variations_NNS in_IN other_JJ regions_NNS of_IN the_DT toxin_NN A_NP and_CC B_NP genes_NNS and_CC in_IN the_DT rest_NN of_IN the_DT genetic_JJ unit_NN ._SENT C._NP difficile_NP Pd3_NP did_VBD not_RB show_VB further_JJR variations_NNS ,_, whereas_IN three_CD fragments_NNS of_IN the_DT C._NP difficile_NN M7_NP PaLoc_NP (_( A1_JJ ,_, encoding_VBG the_DT catalytic_JJ domain_NN of_IN toxin_NN A_DT ;_: B2_NN ,_, encoding_VBG the_DT translocation_NN domain_NN of_IN toxin_NN B_NN ;_: and_CC PL2_NP ,_, located_VBN upstream_IN the_DT tcdB_NN gene_NN )_) showed_VBD different_JJ patterns_NNS than_IN the_DT reference_NN strain_NN C._NP difficile_NN VPI_NP 10463_CD after_IN digestion_NN with_IN specific_JJ enzymes_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT These_DT results_NNS demonstrate_VBP that_IN C._NP difficile_NP M7_NP represents_VBZ a_DT new_JJ toxinotype_NN and_CC indicate_VB ,_, in_IN contrast_NN to_TO the_DT data_NNS already_RB known_VBN ,_, that_IN it_PP is_VBZ also_RB possible_JJ to_TO detect_VB the_DT binary_JJ toxin_NN genes_NNS in_IN strains_NNS with_IN minor_JJ modifications_NNS in_IN tcdA_NN and_CC tcdB_NN genes_NNS ._SENT In_IN this_DT study_NN ,_, we_PP demonstrated_VBD genetic_JJ variability_NN of_IN the_DT tcdC_NN gene_NN ,_, which_WDT codes_VBZ for_IN the_DT supposed_VBN negative_JJ regulator_NN of_IN toxin_NN A_NP and_CC B_NP gene_NN transcription_NN ._SENT Three_CD different_JJ tcdC_NN nucleotide_NN sequences_NNS were_VBD identified_VBN and_CC denominated_VBN types_NNS A_NP ,_, B_NP ,_, and_CC C_NP ._SENT The_DT deletions_NNS characterizing_VBG the_DT tcdC_NN variant_NN genes_NNS are_VBP located_VBN in_IN a_DT DNA_NP region_NN featuring_VBG repeated_JJ sequences_NNS that_WDT code_VBP for_IN eight_CD 3-amino_JJ acid_JJ repeats_NNS of_IN an_DT acidic_JJ or_CC basic_JJ nature_NN ._SENT These_DT DNA_NP regions_NNS show_VBP higher_JJR mutation_NN frequencies_NNS ,_, due_JJ to_TO recombination_NN events_NNS between_IN repeats_NNS ._SENT tcdC_NN type_NN A_DT shows_VBZ a_DT deletion_NN of_IN 39_CD bp_NN ,_, whereas_IN types_NNS B_NP and_CC C_NP show_VBP a_DT deletion_NN of_IN 18_CD bp_NN ._SENT A_DT transition_NN from_IN cytosine_NN to_TO thymine_NN in_IN tcdC-A_NN determines_VBZ a_DT nonsense_JJ mutation_NN ,_, so_RB the_DT tcdC_NN protein_NN has_VBZ only_RB 61_CD amino_NN acids_NNS compared_VBN to_TO the_DT 232_CD expected_VBN ._SENT Type_NN B_NP and_CC C_NP tcdC_NN genes_NNS ,_, in_IN spite_NN of_IN the_DT different_JJ nucleotide_NN sequences_NNS ,_, code_NN for_IN an_DT identical_JJ amino_NN acid_NN sequence_NN ._SENT This_DT protein_NN of_IN 226_CD amino_NN acids_NNS is_VBZ characterized_VBN by_IN the_DT deletion_NN of_IN 6_CD amino_NN acids_NNS ,_, determining_VBG the_DT loss_NN of_IN the_DT basic_JJ repeat_NN KKA_NP and_CC the_DT partial_JJ loss_NN of_IN the_DT acidic_JJ repeats_NNS EEA_NP and_CC EEQ_NP ._SENT It_PP is_VBZ noteworthy_JJ that_IN all_PDT the_DT strains_NNS belonging_VBG to_TO toxinotypes_NNS V_CD ,_, VI_CD ,_, and_CC VII_NP that_WDT were_VBD examined_VBN in_IN this_DT study_NN showed_VBD a_DT TcdC_NP of_IN only_RB 61_CD amino_NN acids_NNS ._SENT A_DT truncated_JJ protein_NN ,_, with_IN a_DT sequence_NN of_IN 22_CD amino_NN acids_NNS ,_, has_VBZ been_VBN previously_RB observed_VBN in_IN C._NP difficile_NN strain_NN 8864_CD ._SENT It_PP has_VBZ been_VBN hypothesized_VBN that_IN this_DT variant_JJ TcdC_NN probably_RB lacks_VBZ its_PP$ function_NN and_CC that_IN it_PP contributes_VBZ to_TO the_DT extreme_JJ cytotoxicity_NN of_IN strain_NN 8864_CD ._SENT All_PDT the_DT C._NP difficile_NN strains_NNS with_IN major_JJ variations_NNS in_IN toxins_NNS A_NP and_CC B_NP examined_VBD in_IN this_DT study_NN showed_VBD high_JJ levels_NNS of_IN cytotoxicity_NN (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT result_NN seems_VBZ to_TO confirm_VB the_DT possibility_NN that_IN the_DT dramatic_JJ modifications_NNS observed_VBN in_IN TcdC_NP could_MD also_RB lead_VB to_TO an_DT altered_JJ function_NN of_IN the_DT protein_NN in_IN these_DT strains_NNS ,_, contributing_VBG to_TO the_DT high_JJ level_NN of_IN toxin_NN expression_NN ._SENT A_DT second_JJ TcdC_NP variant_NN was_VBD identified_VBN both_CC in_IN C._NP difficile_NP Pd3_NP and_CC in_IN C._NP difficile_NN M7_JJ ._SENT The_DT level_NN of_IN cytotoxicity_NN in_IN vitro_NN of_IN M7_JJ was_VBD significantly_RB lower_JJR than_IN that_DT observed_VBN for_IN the_DT other_JJ variant_JJ TcdC_NP strains_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Further_JJR studies_NNS should_MD be_VB performed_VBN to_TO determine_VB the_DT influence_NN of_IN the_DT variant_JJ TcdC_NN on_IN M7_JJ toxin_NN gene_NN transcription_NN and_CC to_TO investigate_VB the_DT functionality_NN of_IN the_DT mutated_VBN toxins_NNS of_IN this_DT strain_NN ._SENT It_PP is_VBZ possible_JJ that_IN different_JJ TcdC_NP variants_NNS have_VBP a_DT different_JJ functionality_NN and_CC diversely_RB affect_VB toxin_NN production_NN ,_, a_DT hypothesis_NN with_IN important_JJ implications_NNS for_IN the_DT pathogenic_JJ potential_NN of_IN C._NP difficile_NN strains_NNS ._SENT Therefore_RB ,_, it_PP could_MD be_VB very_RB interesting_JJ to_TO extend_VB these_DT studies_NNS to_TO all_PDT the_DT other_JJ C._NP difficile_NN toxinotypes_NNS and_CC to_TO investigate_VB the_DT influence_NN of_IN variant_JJ TcdC_NP proteins_NNS on_IN the_DT virulence_NN of_IN this_DT pathogenic_JJ microorganism_NN ._SENT FIG._NN 2_CD ._SENT |_SYM Detection_NP of_IN PaLoc_NP accessory_JJ genes_NNS cdd-3_NN ,_, tcdC_NN ,_, tcdD_NNS ,_, tcdE_NNS ,_, and_CC cdu-2_NN by_IN multiplex_JJ PCR_NP in_IN eight_CD C._NP difficile_NN Detection_NN of_IN PaLoc_NP accessory_JJ genes_NNS cdd-3_NN ,_, tcdC_NN ,_, tcdD_NNS ,_, tcdE_NNS ,_, and_CC cdu-2_NN by_IN multiplex_JJ PCR_NP in_IN eight_CD C._NP difficile_NN strains_NNS with_IN variant_JJ PaLoc_NP genes_NNS identified_VBN in_IN this_DT study_NN ._SENT Lane_NP 1_CD ,_, Pd_NP 5_CD ;_: lane_NN 2_CD ,_, Pd7_JJ ;_: lane_NN 3_CD ,_, Pd13_NP ;_: lane_NN 4_CD ,_, Pd16_NP ;_: lane_NN 5_CD ,_, Pd53_NP ;_: lane_NN 6_CD ,_, Pd_NP 55_CD ;_: lane_NN 7_CD ,_, M7_JJ ;_: lane_NN 8_CD ,_, Pd3_NP ;_: lane_NN 9_CD ,_, DNA_NP molecular_JJ weight_NN marker_NN IX_CD ;_: lane_NN 10_CD ,_, C._NP difficile_NP VPI10463_NP ;_: lane_NN 11_CD ,_, ATCC_NP 43597_CD ;_: lane_NN 12_CD ,_, C._NP difficile_NP 51377_CD ;_: lane_NN 13_CD ,_, C._NP difficile_NP 57267_CD ._SENT FIG._NN 3_CD ._SENT |_SYM Toxinotyping_NP of_IN eight_CD C._NP difficile_NN Toxinotyping_NN of_IN eight_CD C._NP difficile_NN strains_NNS with_IN variant_JJ PaLoc_NP genes_NNS and_CC of_IN the_DT reference_NN strains_VBZ C._NP difficile_NN VPI_NP 10463_CD ,_, C._NP difficile_NP 51377_CD ,_, and_CC C.difficile_NP 57267_CD ._SENT (_( For_IN descriptions_NNS of_IN the_DT other_JJ toxinotypes_NNS ,_, see_VBP Rupnik_NP et_FW al._FW [_SYM ,_, ]_SYM )_) ._SENT The_DT PCR-RFLP_NP patterns_NNS of_IN A3_NP and_CC B1_NP fragments_NNS are_VBP shown_VBN for_IN each_DT strain_NN ._SENT A3_NP fragments_NNS were_VBD digested_VBN with_IN EcoRI_NP (_( E_NP )_) ,_, and_CC B1_NP fragments_NNS were_VBD digested_VBN with_IN HincII_NP (_( H_NP )_) and_CC AccI_NP (_( A_NP )_) ._SENT M_NP ,_, 100-bp_JJ DNA_NN ladder_NN (_( BioLabs_NP )_) ._SENT Pd7_JJ ,_, Pd13_NP ,_, Pd16_NP ,_, and_CC Pd55_NP (_( C._NP difficile_NN strains_NNS )_) ,_, toxinotype_NN V_CD ;_: Pd5_NP and_CC Pd53_NP ,_, toxinotype_NN VI_CD ;_: Pd3_NP and_CC M7_NP ,_, toxinotype_NN 0_CD (_( C._NP difficile_NP M7_NP represents_VBZ a_DT new_JJ toxinotype_NN ,_, as_RB demonstrated_VBN by_IN PCR-RFLP_NP analysis_NN of_IN the_DT entire_JJ PaLoc_NN )_) ._SENT C._NP difficile_NN VPI_NP 10463_CD ,_, C._NP difficile_NP 51377_CD ,_, and_CC C.difficile_NP 57267_CD are_VBP the_DT reference_NN strains_NNS for_IN toxinotypes_NNS 0_CD ,_, VI_CD ,_, and_CC VII_NP ,_, respectively_RB ._SENT FIG._NN 4_CD ._SENT |_SYM Comparison_NN of_IN the_DT TcdC_NP nucleotide_NN and_CC amino_NN acid_NN sequences_NNS of_IN the_DT C._NP difficile_NN Comparison_NN of_IN the_DT TcdC_NP nucleotide_NN and_CC amino_NN acid_NN sequences_NNS of_IN the_DT C._NP difficile_NN reference_NN strain_NN VPI_NP 10463_CD with_IN those_DT of_IN the_DT variant_JJ TcdC_NP proteins_NNS identified_VBN in_IN C._NP difficile_JJ clinical_JJ isolates_NNS examined_VBN in_IN this_DT study_NN ._SENT Dots_NNS and_CC dashes_NNS indicate_VBP identical_JJ bases_NNS and_CC gaps_NNS ,_, respectively_RB ,_, for_IN the_DT different_JJ tcdC_NN alleles_NNS (_( tcdC-A_NP ,_, -B_NN ,_, and_CC -C_NN )_) ._SENT The_DT termination_NN codon_NN in_IN tcdC-A_NN is_VBZ underlined_VBN ._SENT Only_RB the_DT amino_NN acid_NN changes_NNS are_VBP indicated_VBN for_IN each_DT TcdC_NP variant_NN ._SENT The_DT eight_CD 3-amino-acid_JJ repeats_NNS of_IN the_DT VPI_NP 10463_CD TcdC_NP are_VBP indicated_VBN by_IN open_JJ (_( acidic_JJ in_IN nature_NN )_) and_CC grey_JJ (_( basic_JJ in_IN nature_NN )_) boxes_NNS ._SENT TABLE_NN 1_CD |_SYM Molecular_JJ characteristics_NNS of_IN C._NP difficile_JJ strains_NNS with_IN variant_JJ PaLoc_NP genes_NNS analyzed_VBD in_IN this_DT study_NN The_DT nucleotide_NN sequences_NNS of_IN the_DT tcdC_NN genes_NNS of_IN C._NP difficile_NN strains_NNS Pd5_NP ,_, Pd3_NP ,_, and_CC M7_JJ were_VBD assigned_VBN EMBL_NP numbers_NNS AJ428941_NP ,_, AJ428942_NP ,_, and_CC AJ428943_NP ,_, respectively_RB ._SENT 